

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | phosphate ion transport (GO:0006817) | 9.55403444 |
| 2 | histone H2A acetylation (GO:0043968) | 8.64777060 |
| 3 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 8.43090570 |
| 4 | urate metabolic process (GO:0046415) | 7.43246521 |
| 5 | phosphate ion transmembrane transport (GO:0035435) | 7.21997977 |
| 6 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 6.79369655 |
| 7 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 6.79369655 |
| 8 | mitochondrion distribution (GO:0048311) | 6.11745785 |
| 9 | tachykinin receptor signaling pathway (GO:0007217) | 5.93248604 |
| 10 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 5.61677808 |
| 11 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 5.57632409 |
| 12 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 5.53832884 |
| 13 | response to parathyroid hormone (GO:0071107) | 5.47096024 |
| 14 | regulation of catecholamine metabolic process (GO:0042069) | 5.41749093 |
| 15 | regulation of dopamine metabolic process (GO:0042053) | 5.41749093 |
| 16 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.36917134 |
| 17 | negative regulation of cAMP-mediated signaling (GO:0043951) | 5.36300850 |
| 18 | regulation of hippo signaling (GO:0035330) | 5.30904087 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.16183781 |
| 20 | multicellular organism reproduction (GO:0032504) | 4.98448666 |
| 21 | response to mercury ion (GO:0046689) | 4.87219810 |
| 22 | negative regulation of protein localization to cell surface (GO:2000009) | 4.73980109 |
| 23 | regulation of neurotransmitter uptake (GO:0051580) | 4.72009718 |
| 24 | transmission of nerve impulse (GO:0019226) | 4.57883637 |
| 25 | behavioral response to cocaine (GO:0048148) | 4.56140159 |
| 26 | positive regulation of action potential (GO:0045760) | 4.33001994 |
| 27 | sensory perception of taste (GO:0050909) | 4.23827985 |
| 28 | adaptation of signaling pathway (GO:0023058) | 4.20904490 |
| 29 | regulation of uterine smooth muscle contraction (GO:0070472) | 4.18092790 |
| 30 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.15129184 |
| 31 | regulation of natural killer cell differentiation (GO:0032823) | 4.13451037 |
| 32 | trivalent inorganic anion homeostasis (GO:0072506) | 4.03535402 |
| 33 | phosphate ion homeostasis (GO:0055062) | 4.03535402 |
| 34 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.03197617 |
| 35 | energy homeostasis (GO:0097009) | 4.02960914 |
| 36 | behavioral response to ethanol (GO:0048149) | 3.99118578 |
| 37 | peristalsis (GO:0030432) | 3.97398642 |
| 38 | behavioral response to nicotine (GO:0035095) | 3.86506353 |
| 39 | synaptic transmission, dopaminergic (GO:0001963) | 3.86067530 |
| 40 | response to lead ion (GO:0010288) | 3.79872947 |
| 41 | regulation of RNA export from nucleus (GO:0046831) | 3.79655010 |
| 42 | positive regulation of heart rate (GO:0010460) | 3.78145919 |
| 43 | hyperosmotic salinity response (GO:0042538) | 3.75365804 |
| 44 | negative regulation of heart rate (GO:0010459) | 3.67007301 |
| 45 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.64569105 |
| 46 | regulation of penile erection (GO:0060405) | 3.63641082 |
| 47 | positive regulation of amine transport (GO:0051954) | 3.60771532 |
| 48 | short-term memory (GO:0007614) | 3.60657991 |
| 49 | specification of organ identity (GO:0010092) | 3.59180446 |
| 50 | positive regulation of calcium ion import (GO:0090280) | 3.55375289 |
| 51 | response to vitamin A (GO:0033189) | 3.55046249 |
| 52 | positive regulation of signal transduction by p53 class mediator (GO:1901798) | 3.54763203 |
| 53 | sperm-egg recognition (GO:0035036) | 3.52128598 |
| 54 | binding of sperm to zona pellucida (GO:0007339) | 3.49794647 |
| 55 | histone H4-K12 acetylation (GO:0043983) | 3.48469182 |
| 56 | positive regulation of catecholamine secretion (GO:0033605) | 3.46247842 |
| 57 | positive regulation of membrane potential (GO:0045838) | 3.42968053 |
| 58 | regulation of feeding behavior (GO:0060259) | 3.40375441 |
| 59 | detection of bacterium (GO:0016045) | 3.37448131 |
| 60 | response to magnesium ion (GO:0032026) | 3.37352987 |
| 61 | epoxygenase P450 pathway (GO:0019373) | 3.37126197 |
| 62 | hindbrain development (GO:0030902) | 3.28744596 |
| 63 | chemosensory behavior (GO:0007635) | 3.25285117 |
| 64 | reproduction (GO:0000003) | 3.20149327 |
| 65 | indole-containing compound metabolic process (GO:0042430) | 3.19702767 |
| 66 | maternal behavior (GO:0042711) | 3.17899256 |
| 67 | regulation of G0 to G1 transition (GO:0070316) | 3.09985452 |
| 68 | cell-cell recognition (GO:0009988) | 3.09874248 |
| 69 | xenobiotic catabolic process (GO:0042178) | 3.07658020 |
| 70 | detection of light stimulus involved in visual perception (GO:0050908) | 3.07284289 |
| 71 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.07284289 |
| 72 | opioid receptor signaling pathway (GO:0038003) | 3.05057167 |
| 73 | regulation of action potential (GO:0098900) | 3.00480931 |
| 74 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.98513105 |
| 75 | glycoprotein catabolic process (GO:0006516) | 2.96586737 |
| 76 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.96355866 |
| 77 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.94314356 |
| 78 | negative regulation of JAK-STAT cascade (GO:0046426) | 2.94162291 |
| 79 | detection of other organism (GO:0098543) | 2.93875746 |
| 80 | negative regulation of dendrite development (GO:2000171) | 2.92958040 |
| 81 | prenylation (GO:0097354) | 2.92650518 |
| 82 | protein prenylation (GO:0018342) | 2.92650518 |
| 83 | mitochondrion localization (GO:0051646) | 2.91592058 |
| 84 | positive regulation of protein kinase C signaling (GO:0090037) | 2.91550007 |
| 85 | head development (GO:0060322) | 2.90113985 |
| 86 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.88576064 |
| 87 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.88119513 |
| 88 | DNA methylation involved in gamete generation (GO:0043046) | 2.85513732 |
| 89 | positive regulation of heart contraction (GO:0045823) | 2.84203288 |
| 90 | parental behavior (GO:0060746) | 2.80235753 |
| 91 | positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517) | 2.79086372 |
| 92 | pentose metabolic process (GO:0019321) | 2.78807377 |
| 93 | chromatin silencing (GO:0006342) | 2.78573025 |
| 94 | response to growth hormone (GO:0060416) | 2.78170168 |
| 95 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.73332928 |
| 96 | negative regulation of cation channel activity (GO:2001258) | 2.71626548 |
| 97 | positive regulation of T cell chemotaxis (GO:0010820) | 2.70366970 |
| 98 | regulation of T cell chemotaxis (GO:0010819) | 2.70366970 |
| 99 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.68823240 |
| 100 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.68349104 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.66191707 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.03184200 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.46087828 |
| 4 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 3.32474465 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.20424076 |
| 6 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.80336115 |
| 7 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.55927738 |
| 8 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.53844917 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.40905710 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.34276320 |
| 11 | FUS_26573619_Chip-Seq_HEK293_Human | 2.32443692 |
| 12 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.23645730 |
| 13 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.23579762 |
| 14 | RXR_22108803_ChIP-Seq_LS180_Human | 2.01660207 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.96604942 |
| 16 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.90054610 |
| 17 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.87763821 |
| 18 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.76889049 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.76798193 |
| 20 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.75678017 |
| 21 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.75597731 |
| 22 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.74331705 |
| 23 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.72768606 |
| 24 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.71448047 |
| 25 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.70507771 |
| 26 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.65980978 |
| 27 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.65980978 |
| 28 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.61006310 |
| 29 | STAT3_23295773_ChIP-Seq_U87_Human | 1.60607593 |
| 30 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.59737229 |
| 31 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.59331875 |
| 32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.58526046 |
| 33 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.57981132 |
| 34 | VDR_22108803_ChIP-Seq_LS180_Human | 1.57797186 |
| 35 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.55750434 |
| 36 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.55591487 |
| 37 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.53301921 |
| 38 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.50410520 |
| 39 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.49804197 |
| 40 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.47872491 |
| 41 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.47572865 |
| 42 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.47434778 |
| 43 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.47154669 |
| 44 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.44963756 |
| 45 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.43075689 |
| 46 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.42364710 |
| 47 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.41281355 |
| 48 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.40628067 |
| 49 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.38336298 |
| 50 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.34428910 |
| 51 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.33571814 |
| 52 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.31661001 |
| 53 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.31637206 |
| 54 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.31533202 |
| 55 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.28572399 |
| 56 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.27842452 |
| 57 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.27808018 |
| 58 | P300_19829295_ChIP-Seq_ESCs_Human | 1.27322031 |
| 59 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.24428973 |
| 60 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.24178098 |
| 61 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.22993370 |
| 62 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.22881562 |
| 63 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22693331 |
| 64 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.19900285 |
| 65 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.19793570 |
| 66 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.19667255 |
| 67 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.18043496 |
| 68 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.17889856 |
| 69 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14732630 |
| 70 | KDM2B_26808549_Chip-Seq_REH_Human | 1.13400829 |
| 71 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.11701484 |
| 72 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.11080966 |
| 73 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.10026418 |
| 74 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.08276263 |
| 75 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.07913712 |
| 76 | ERA_21632823_ChIP-Seq_H3396_Human | 1.05106280 |
| 77 | CJUN_26792858_Chip-Seq_BT549_Human | 1.04679190 |
| 78 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.04553106 |
| 79 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03834833 |
| 80 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 1.03698463 |
| 81 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03604359 |
| 82 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.01515770 |
| 83 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.00768903 |
| 84 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.99349022 |
| 85 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.98692060 |
| 86 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.98495977 |
| 87 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97343046 |
| 88 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.97060130 |
| 89 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.96313538 |
| 90 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.95398853 |
| 91 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.94986938 |
| 92 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.94795008 |
| 93 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.92323420 |
| 94 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91841639 |
| 95 | PPARD_21283829_ChIP-Seq_MYOFIBROBLAST_Human | 0.91112859 |
| 96 | * NCOR_22424771_ChIP-Seq_293T_Human | 0.90964630 |
| 97 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.90392546 |
| 98 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89714770 |
| 99 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.89478772 |
| 100 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.89266468 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003878_abnormal_ear_physiology | 4.07777622 |
| 2 | MP0005377_hearing/vestibular/ear_phenot | 4.07777622 |
| 3 | MP0002138_abnormal_hepatobiliary_system | 3.39431154 |
| 4 | MP0004510_myositis | 3.04448062 |
| 5 | MP0005397_hematopoietic_system_phenotyp | 2.99990164 |
| 6 | MP0001545_abnormal_hematopoietic_system | 2.99990164 |
| 7 | MP0002332_abnormal_exercise_endurance | 2.98873942 |
| 8 | MP0005645_abnormal_hypothalamus_physiol | 2.65568916 |
| 9 | MP0002160_abnormal_reproductive_system | 2.64702857 |
| 10 | MP0003045_fibrosis | 2.53806190 |
| 11 | MP0005410_abnormal_fertilization | 2.53181186 |
| 12 | MP0004859_abnormal_synaptic_plasticity | 2.46735083 |
| 13 | MP0001348_abnormal_lacrimal_gland | 2.42352686 |
| 14 | MP0001486_abnormal_startle_reflex | 2.09460569 |
| 15 | MP0002735_abnormal_chemical_nociception | 2.08681610 |
| 16 | MP0001485_abnormal_pinna_reflex | 2.05969011 |
| 17 | MP0005551_abnormal_eye_electrophysiolog | 2.05727102 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 1.90731320 |
| 19 | MP0005423_abnormal_somatic_nervous | 1.85732493 |
| 20 | MP0006276_abnormal_autonomic_nervous | 1.84500505 |
| 21 | MP0003315_abnormal_perineum_morphology | 1.80557715 |
| 22 | MP0003252_abnormal_bile_duct | 1.80547771 |
| 23 | MP0003136_yellow_coat_color | 1.78799415 |
| 24 | MP0010386_abnormal_urinary_bladder | 1.74988319 |
| 25 | MP0003635_abnormal_synaptic_transmissio | 1.68956327 |
| 26 | MP0008775_abnormal_heart_ventricle | 1.67828372 |
| 27 | MP0005670_abnormal_white_adipose | 1.64846833 |
| 28 | MP0001501_abnormal_sleep_pattern | 1.62475984 |
| 29 | MP0004147_increased_porphyrin_level | 1.60850044 |
| 30 | MP0001905_abnormal_dopamine_level | 1.57992414 |
| 31 | MP0002063_abnormal_learning/memory/cond | 1.57912141 |
| 32 | MP0004808_abnormal_hematopoietic_stem | 1.56182906 |
| 33 | MP0000383_abnormal_hair_follicle | 1.55364408 |
| 34 | MP0005319_abnormal_enzyme/_coenzyme | 1.54043056 |
| 35 | MP0008004_abnormal_stomach_pH | 1.51913710 |
| 36 | MP0000427_abnormal_hair_cycle | 1.51551494 |
| 37 | MP0000747_muscle_weakness | 1.48572709 |
| 38 | MP0005360_urolithiasis | 1.46301911 |
| 39 | MP0004782_abnormal_surfactant_physiolog | 1.42723160 |
| 40 | MP0002928_abnormal_bile_duct | 1.41810121 |
| 41 | MP0002733_abnormal_thermal_nociception | 1.40110410 |
| 42 | MP0000749_muscle_degeneration | 1.40092423 |
| 43 | MP0002572_abnormal_emotion/affect_behav | 1.37589272 |
| 44 | MP0000678_abnormal_parathyroid_gland | 1.36853167 |
| 45 | MP0004085_abnormal_heartbeat | 1.35851676 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.33352860 |
| 47 | MP0004133_heterotaxia | 1.32946372 |
| 48 | MP0004215_abnormal_myocardial_fiber | 1.32803825 |
| 49 | MP0000538_abnormal_urinary_bladder | 1.32668906 |
| 50 | MP0009745_abnormal_behavioral_response | 1.31384266 |
| 51 | MP0001984_abnormal_olfaction | 1.31126484 |
| 52 | MP0010678_abnormal_skin_adnexa | 1.30210462 |
| 53 | MP0005367_renal/urinary_system_phenotyp | 1.28590230 |
| 54 | MP0000516_abnormal_urinary_system | 1.28590230 |
| 55 | MP0005647_abnormal_sex_gland | 1.28538860 |
| 56 | MP0005389_reproductive_system_phenotype | 1.27462731 |
| 57 | MP0005195_abnormal_posterior_eye | 1.26805135 |
| 58 | MP0006138_congestive_heart_failure | 1.24972555 |
| 59 | MP0006072_abnormal_retinal_apoptosis | 1.24920604 |
| 60 | MP0009333_abnormal_splenocyte_physiolog | 1.20183960 |
| 61 | MP0003698_abnormal_male_reproductive | 1.17680325 |
| 62 | MP0009046_muscle_twitch | 1.14073266 |
| 63 | MP0004858_abnormal_nervous_system | 1.08087213 |
| 64 | MP0001970_abnormal_pain_threshold | 1.07876179 |
| 65 | MP0001849_ear_inflammation | 1.07312401 |
| 66 | MP0003283_abnormal_digestive_organ | 1.06349511 |
| 67 | MP0003959_abnormal_lean_body | 1.03857259 |
| 68 | MP0009765_abnormal_xenobiotic_induced | 1.01524539 |
| 69 | MP0002184_abnormal_innervation | 1.01250368 |
| 70 | MP0005220_abnormal_exocrine_pancreas | 1.01138656 |
| 71 | MP0002752_abnormal_somatic_nervous | 0.98642862 |
| 72 | MP0000604_amyloidosis | 0.98244280 |
| 73 | MP0010368_abnormal_lymphatic_system | 0.97861711 |
| 74 | MP0002272_abnormal_nervous_system | 0.97195129 |
| 75 | MP0004272_abnormal_basement_membrane | 0.95822419 |
| 76 | MP0000955_abnormal_spinal_cord | 0.94534649 |
| 77 | MP0001765_abnormal_ion_homeostasis | 0.92397598 |
| 78 | MP0002971_abnormal_brown_adipose | 0.91786098 |
| 79 | MP0009672_abnormal_birth_weight | 0.90551717 |
| 80 | MP0000462_abnormal_digestive_system | 0.87482501 |
| 81 | MP0002168_other_aberrant_phenotype | 0.85099173 |
| 82 | MP0000465_gastrointestinal_hemorrhage | 0.84864434 |
| 83 | MP0001764_abnormal_homeostasis | 0.83645809 |
| 84 | MP0002067_abnormal_sensory_capabilities | 0.83199548 |
| 85 | MP0008877_abnormal_DNA_methylation | 0.81688870 |
| 86 | MP0001664_abnormal_digestion | 0.81155046 |
| 87 | MP0006035_abnormal_mitochondrial_morpho | 0.79174650 |
| 88 | MP0003880_abnormal_central_pattern | 0.77730703 |
| 89 | MP0002069_abnormal_eating/drinking_beha | 0.76391536 |
| 90 | MP0002229_neurodegeneration | 0.76152275 |
| 91 | MP0001293_anophthalmia | 0.75063351 |
| 92 | MP0005266_abnormal_metabolism | 0.74937815 |
| 93 | MP0001963_abnormal_hearing_physiology | 0.74639827 |
| 94 | MP0002734_abnormal_mechanical_nocicepti | 0.73549932 |
| 95 | MP0005253_abnormal_eye_physiology | 0.73530837 |
| 96 | MP0003943_abnormal_hepatobiliary_system | 0.71940467 |
| 97 | MP0005187_abnormal_penis_morphology | 0.71922242 |
| 98 | MP0001929_abnormal_gametogenesis | 0.70367913 |
| 99 | MP0001756_abnormal_urination | 0.70316127 |
| 100 | MP0004145_abnormal_muscle_electrophysio | 0.70209130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Generalized aminoaciduria (HP:0002909) | 9.43027363 |
| 2 | Proximal tubulopathy (HP:0000114) | 6.93423407 |
| 3 | Severe visual impairment (HP:0001141) | 6.60762113 |
| 4 | Pendular nystagmus (HP:0012043) | 6.57054023 |
| 5 | Congenital stationary night blindness (HP:0007642) | 5.79072285 |
| 6 | Popliteal pterygium (HP:0009756) | 5.10390007 |
| 7 | Fetal akinesia sequence (HP:0001989) | 4.74200540 |
| 8 | Myokymia (HP:0002411) | 4.50510195 |
| 9 | True hermaphroditism (HP:0010459) | 4.09393231 |
| 10 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.93303428 |
| 11 | Pancreatic fibrosis (HP:0100732) | 3.89428875 |
| 12 | Amniotic constriction ring (HP:0009775) | 3.81310736 |
| 13 | Abnormality of placental membranes (HP:0011409) | 3.81310736 |
| 14 | Pancreatic cysts (HP:0001737) | 3.74547217 |
| 15 | Tongue fasciculations (HP:0001308) | 3.62737517 |
| 16 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.43900739 |
| 17 | Abolished electroretinogram (ERG) (HP:0000550) | 3.29484959 |
| 18 | Acute lymphatic leukemia (HP:0006721) | 3.27944302 |
| 19 | Cystic liver disease (HP:0006706) | 3.27206980 |
| 20 | Attenuation of retinal blood vessels (HP:0007843) | 3.22513118 |
| 21 | Increased corneal curvature (HP:0100692) | 3.19821274 |
| 22 | Keratoconus (HP:0000563) | 3.19821274 |
| 23 | Muscle fibrillation (HP:0010546) | 3.16778367 |
| 24 | Hyperkalemia (HP:0002153) | 3.07145980 |
| 25 | Clumsiness (HP:0002312) | 3.03726199 |
| 26 | Abnormality of urine glucose concentration (HP:0011016) | 2.94350964 |
| 27 | Glycosuria (HP:0003076) | 2.94350964 |
| 28 | Aplasia of the musculature (HP:0100854) | 2.86621159 |
| 29 | Retinal atrophy (HP:0001105) | 2.77531634 |
| 30 | Rib fusion (HP:0000902) | 2.72403359 |
| 31 | Thoracic kyphosis (HP:0002942) | 2.71583710 |
| 32 | Malignant hyperthermia (HP:0002047) | 2.68275587 |
| 33 | Sclerocornea (HP:0000647) | 2.53999251 |
| 34 | Congenital sensorineural hearing impairment (HP:0008527) | 2.51041228 |
| 35 | Optic nerve hypoplasia (HP:0000609) | 2.49954335 |
| 36 | Anencephaly (HP:0002323) | 2.49787991 |
| 37 | Retinal dysplasia (HP:0007973) | 2.44821889 |
| 38 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.42744100 |
| 39 | Decreased central vision (HP:0007663) | 2.42596575 |
| 40 | Poor eye contact (HP:0000817) | 2.38768936 |
| 41 | Cystic hygroma (HP:0000476) | 2.38245223 |
| 42 | Abnormality of macular pigmentation (HP:0008002) | 2.36875617 |
| 43 | Genetic anticipation (HP:0003743) | 2.32313060 |
| 44 | Chorioretinal atrophy (HP:0000533) | 2.31583136 |
| 45 | Abnormality of DNA repair (HP:0003254) | 2.30091564 |
| 46 | Male pseudohermaphroditism (HP:0000037) | 2.28921445 |
| 47 | Abnormality of the renal collecting system (HP:0004742) | 2.28459954 |
| 48 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.28245789 |
| 49 | Abnormality of the columella (HP:0009929) | 2.27270399 |
| 50 | Renal dysplasia (HP:0000110) | 2.25875055 |
| 51 | Decreased circulating renin level (HP:0003351) | 2.22650918 |
| 52 | Bile duct proliferation (HP:0001408) | 2.20234214 |
| 53 | Abnormal biliary tract physiology (HP:0012439) | 2.20234214 |
| 54 | Furrowed tongue (HP:0000221) | 2.20107951 |
| 55 | Action tremor (HP:0002345) | 2.19212924 |
| 56 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.18501915 |
| 57 | Abnormality of the labia majora (HP:0012881) | 2.17517577 |
| 58 | Rickets (HP:0002748) | 2.16932081 |
| 59 | Fused cervical vertebrae (HP:0002949) | 2.14335463 |
| 60 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.07911450 |
| 61 | Stenosis of the external auditory canal (HP:0000402) | 2.06159338 |
| 62 | Severe muscular hypotonia (HP:0006829) | 2.04895775 |
| 63 | Hypercalciuria (HP:0002150) | 2.03103842 |
| 64 | Abnormality of the lumbar spine (HP:0100712) | 2.02054874 |
| 65 | Poikiloderma (HP:0001029) | 2.02017587 |
| 66 | Hydroxyprolinuria (HP:0003080) | 1.99584465 |
| 67 | Abnormality of proline metabolism (HP:0010907) | 1.99584465 |
| 68 | Submucous cleft hard palate (HP:0000176) | 1.98216278 |
| 69 | Pterygium (HP:0001059) | 1.97934389 |
| 70 | Morphological abnormality of the middle ear (HP:0008609) | 1.96573391 |
| 71 | J-shaped sella turcica (HP:0002680) | 1.95969738 |
| 72 | Recurrent corneal erosions (HP:0000495) | 1.94865906 |
| 73 | Parakeratosis (HP:0001036) | 1.94169933 |
| 74 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.94093114 |
| 75 | Hyperphosphaturia (HP:0003109) | 1.93627778 |
| 76 | Absent speech (HP:0001344) | 1.92348505 |
| 77 | Congenital hepatic fibrosis (HP:0002612) | 1.88343349 |
| 78 | Neonatal death (HP:0003811) | 1.87030567 |
| 79 | Pigmentary retinal degeneration (HP:0001146) | 1.86521171 |
| 80 | Abnormal auditory evoked potentials (HP:0006958) | 1.85608081 |
| 81 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.81821892 |
| 82 | Postaxial foot polydactyly (HP:0001830) | 1.81817115 |
| 83 | Pachygyria (HP:0001302) | 1.80896862 |
| 84 | Neonatal respiratory distress (HP:0002643) | 1.80542510 |
| 85 | Focal seizures (HP:0007359) | 1.78374860 |
| 86 | Upper limb muscle weakness (HP:0003484) | 1.77754066 |
| 87 | Rocker bottom foot (HP:0001838) | 1.77177353 |
| 88 | Abnormality of chloride homeostasis (HP:0011422) | 1.71257898 |
| 89 | Type 2 muscle fiber atrophy (HP:0003554) | 1.71145370 |
| 90 | Nonprogressive disorder (HP:0003680) | 1.70050976 |
| 91 | Gait imbalance (HP:0002141) | 1.69773653 |
| 92 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.68518821 |
| 93 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.68280843 |
| 94 | Akinesia (HP:0002304) | 1.67898601 |
| 95 | Type II lissencephaly (HP:0007260) | 1.67645807 |
| 96 | Impaired social interactions (HP:0000735) | 1.66653718 |
| 97 | Abnormal social behavior (HP:0012433) | 1.66653718 |
| 98 | Intellectual disability, progressive (HP:0006887) | 1.64576386 |
| 99 | Erectile abnormalities (HP:0100639) | 1.63115497 |
| 100 | Oligodontia (HP:0000677) | 1.62546314 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK19 | 6.54512655 |
| 2 | PRPF4B | 6.37862975 |
| 3 | TAOK2 | 4.78589726 |
| 4 | FRK | 3.83707388 |
| 5 | PINK1 | 3.44960282 |
| 6 | INSRR | 2.70995106 |
| 7 | LATS1 | 2.45705209 |
| 8 | ADRBK2 | 2.29775763 |
| 9 | TXK | 2.05603604 |
| 10 | MARK1 | 2.05518893 |
| 11 | MST1R | 1.80373745 |
| 12 | BMPR1B | 1.64671902 |
| 13 | AURKA | 1.60862638 |
| 14 | OBSCN | 1.39902740 |
| 15 | PRKD3 | 1.30091187 |
| 16 | PHKG2 | 1.27503858 |
| 17 | PHKG1 | 1.27503858 |
| 18 | GRK1 | 1.25579511 |
| 19 | RPS6KA5 | 1.25401497 |
| 20 | GRK7 | 1.23365957 |
| 21 | OXSR1 | 1.16629312 |
| 22 | MOS | 1.12297740 |
| 23 | FGFR2 | 1.10946008 |
| 24 | TYRO3 | 1.06037131 |
| 25 | LATS2 | 1.00785140 |
| 26 | CDK8 | 0.99589151 |
| 27 | NTRK3 | 0.98291038 |
| 28 | MAPK13 | 0.98034212 |
| 29 | TGFBR1 | 0.96061607 |
| 30 | DAPK2 | 0.93367856 |
| 31 | MAP3K7 | 0.90755158 |
| 32 | PRKG2 | 0.89609261 |
| 33 | MARK3 | 0.87189062 |
| 34 | TLK1 | 0.86846881 |
| 35 | PRKAA1 | 0.83935986 |
| 36 | FER | 0.82808615 |
| 37 | TGFBR2 | 0.81797537 |
| 38 | DYRK2 | 0.80395301 |
| 39 | PRKCG | 0.77697412 |
| 40 | MAP2K7 | 0.75879327 |
| 41 | MYLK | 0.74700616 |
| 42 | CASK | 0.74225986 |
| 43 | MAP4K2 | 0.73123756 |
| 44 | CHEK2 | 0.71808031 |
| 45 | CDK12 | 0.71143678 |
| 46 | PDGFRA | 0.70431480 |
| 47 | ZAK | 0.69741421 |
| 48 | EEF2K | 0.68772980 |
| 49 | PKN1 | 0.68762440 |
| 50 | ERBB3 | 0.68129327 |
| 51 | RPS6KA4 | 0.63046047 |
| 52 | SGK223 | 0.62937138 |
| 53 | SGK494 | 0.62937138 |
| 54 | TRPM7 | 0.61821452 |
| 55 | MAP2K6 | 0.60927304 |
| 56 | RPS6KB2 | 0.60162307 |
| 57 | PTK2B | 0.59359653 |
| 58 | PRKACB | 0.57480777 |
| 59 | DDR2 | 0.56695440 |
| 60 | MAPKAPK3 | 0.56203770 |
| 61 | MET | 0.55469159 |
| 62 | PRKCH | 0.54799348 |
| 63 | STK11 | 0.53367510 |
| 64 | WNK3 | 0.50805080 |
| 65 | PRKCD | 0.48559113 |
| 66 | MAP4K1 | 0.47681349 |
| 67 | GRK5 | 0.45797362 |
| 68 | JAK3 | 0.45330458 |
| 69 | MAP2K1 | 0.43551617 |
| 70 | CAMK2B | 0.43443678 |
| 71 | MAPK10 | 0.41618739 |
| 72 | CSNK1A1 | 0.41218156 |
| 73 | CHEK1 | 0.40701147 |
| 74 | PRKACA | 0.39450726 |
| 75 | PAK1 | 0.39187676 |
| 76 | MUSK | 0.39144975 |
| 77 | ADRBK1 | 0.39024470 |
| 78 | BCKDK | 0.38872438 |
| 79 | MARK2 | 0.38075166 |
| 80 | EGFR | 0.37962419 |
| 81 | RPS6KB1 | 0.36707377 |
| 82 | ILK | 0.36044196 |
| 83 | CSNK1A1L | 0.35826269 |
| 84 | RPS6KA2 | 0.35756496 |
| 85 | CSNK1E | 0.34301853 |
| 86 | CSNK1G3 | 0.33793456 |
| 87 | INSR | 0.33739761 |
| 88 | RPS6KA3 | 0.32191296 |
| 89 | MAPK8 | 0.31993485 |
| 90 | CAMK2A | 0.31323086 |
| 91 | IRAK3 | 0.31234077 |
| 92 | TIE1 | 0.28390107 |
| 93 | PDK1 | 0.28065819 |
| 94 | NTRK2 | 0.27950970 |
| 95 | SRC | 0.27694232 |
| 96 | STK38L | 0.27376880 |
| 97 | STK38 | 0.26965579 |
| 98 | TNK2 | 0.26486131 |
| 99 | SYK | 0.26203847 |
| 100 | PRKCE | 0.24941019 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Renin-angiotensin system_Homo sapiens_hsa04614 | 5.74708274 |
| 2 | Phototransduction_Homo sapiens_hsa04744 | 3.14916490 |
| 3 | Taste transduction_Homo sapiens_hsa04742 | 2.98923453 |
| 4 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.89188689 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.87101500 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 2.62524968 |
| 7 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.61392967 |
| 8 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.34671265 |
| 9 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.22612459 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14499417 |
| 11 | Retinol metabolism_Homo sapiens_hsa00830 | 2.14323819 |
| 12 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.98301581 |
| 13 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.97745852 |
| 14 | Gap junction_Homo sapiens_hsa04540 | 1.88425637 |
| 15 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.87325816 |
| 16 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.76794765 |
| 17 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.73280168 |
| 18 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.70536544 |
| 19 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.63005900 |
| 20 | Sulfur relay system_Homo sapiens_hsa04122 | 1.48617915 |
| 21 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.41622768 |
| 22 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.40197198 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38332062 |
| 24 | Morphine addiction_Homo sapiens_hsa05032 | 1.36734270 |
| 25 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.29015618 |
| 26 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.24912081 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.24610917 |
| 28 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.23493750 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.16646027 |
| 30 | Olfactory transduction_Homo sapiens_hsa04740 | 1.16324117 |
| 31 | GABAergic synapse_Homo sapiens_hsa04727 | 1.15787969 |
| 32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.13036264 |
| 33 | ABC transporters_Homo sapiens_hsa02010 | 1.11238540 |
| 34 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.10815129 |
| 35 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.09652437 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.05675093 |
| 37 | Renin secretion_Homo sapiens_hsa04924 | 1.02214696 |
| 38 | Salivary secretion_Homo sapiens_hsa04970 | 1.01171385 |
| 39 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.00979556 |
| 40 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.99506061 |
| 41 | Cocaine addiction_Homo sapiens_hsa05030 | 0.98474455 |
| 42 | Circadian entrainment_Homo sapiens_hsa04713 | 0.97269623 |
| 43 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.97230372 |
| 44 | Circadian rhythm_Homo sapiens_hsa04710 | 0.94413733 |
| 45 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93027457 |
| 46 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.90730595 |
| 47 | Axon guidance_Homo sapiens_hsa04360 | 0.86203155 |
| 48 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.86117731 |
| 49 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.83414938 |
| 50 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.80383496 |
| 51 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76949854 |
| 52 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.74192918 |
| 53 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.71934390 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.71878330 |
| 55 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.70006895 |
| 56 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69108624 |
| 57 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.65617104 |
| 58 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.63707802 |
| 59 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.62241784 |
| 60 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61531976 |
| 61 | Alcoholism_Homo sapiens_hsa05034 | 0.60547786 |
| 62 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.59365291 |
| 63 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.58838165 |
| 64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.58595497 |
| 65 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.58380396 |
| 66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.57956680 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57926182 |
| 68 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.57890953 |
| 69 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.57572004 |
| 70 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55252419 |
| 71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.54011148 |
| 72 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52872925 |
| 73 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.52763805 |
| 74 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.51647217 |
| 75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.50388588 |
| 76 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.49299339 |
| 77 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45477234 |
| 78 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.45185177 |
| 79 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.43763702 |
| 80 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.42370556 |
| 81 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.39894525 |
| 82 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39377357 |
| 83 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.37319329 |
| 84 | Peroxisome_Homo sapiens_hsa04146 | 0.36458085 |
| 85 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.35139099 |
| 86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.34593499 |
| 87 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.33293059 |
| 88 | Homologous recombination_Homo sapiens_hsa03440 | 0.33175515 |
| 89 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.31861253 |
| 90 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.31197855 |
| 91 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.30461156 |
| 92 | Histidine metabolism_Homo sapiens_hsa00340 | 0.28639237 |
| 93 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.28394488 |
| 94 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.27811521 |
| 95 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.26618991 |
| 96 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.25233998 |
| 97 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.24791439 |
| 98 | Other glycan degradation_Homo sapiens_hsa00511 | 0.24695211 |
| 99 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.24214521 |
| 100 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.22212749 |

